The formation of fibrillar tangles of the Tau protein is crucial in the development of Alzheimer's disease. Biophysical methods based on labelling of the cysteines of Tau with fluorescence dyes would allow to study fibril formation with an 'internal eye'.
Introduction
The intrinsically disordered Tau protein is involved in stabilisation and organisation of axonal microtubule bundles due to its microtubule-binding and tubulin-polymerising activity 1, 2 . Tau is abundant in neurons, especially in axons and its aggregation into paired helical filaments and neurofibrillary tangles are the key hallmarks of multiple neurodegenerative disorders, including Alzheimer's disease (AD) and other tauopathies [3] [4] [5] [6] . Notably, the literature refers to fibril formation of Tau as aggregation. However, when
Tau aggregates it always assembles into structurally defined fibrils, Tau does not form amorphous aggregates.
Aggregation enhancers facilitate fibril formation of Tau and a variety of methods allow monitoring fibrils. As the first step of the process the structural ensemble of Tau undergoes significant transitions which leads to oligomers of Tau 7 . Subsequently, oligomers are elongated and form long, insoluble fibrils 8 . During fibril formation the highly soluble, unfolded Tau enriches in β-sheet elements and adopts a combined cross-β/β-helix structure [9] [10] [11] . Recent studies suggest that oligomeric Tau species, rather than fibrils, are responsible for cellular toxicity and disease pathology. However, the mechanism of oligomer toxicity is poorly understood [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Tau consists of two major domains of which the repeat domain (Tau-RD) in the assembly domain primarily drives fibril formation ( Figure 1A ) 21 . It is not yet known how the projection domain and the connecting proline rich region influence polymerisation.
However, the termini of Tau are suggested to have an aggregation inhibitory effect by folding on the Tau-RD and preventing its self-association 22, 23 . The Tau-RD, depending on alternative splicing, consists of three or four pseudorepeats that form the core of the paired helical filaments upon Tau aggregation 21, 24, 25 . The minimal motifs of the Tau-RD that were shown to be necessary for Tau aggregation in vitro are the ( 275 VQIINK 280 ) and ( 306 VQIVYK 311 ) hexapeptides, located in the second and third repeats, respectively ( Figure 1B ) 26 . A recent high resolution Cryo-EM structural model of Tau paired helical filaments from an Alzheimer's patient suggests that the filament core consists of two identical copies comprising the residues of V306-F378 9 . Additionally, a section N-
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Tau has two native cysteine residues, one located in the filament core and the other on the region that folds back on the core (Figure 1B ) 9 . It is controversial to which extent they contribute to or even drive aggregation. It was shown that Tau molecules form covalent dimers via intermolecular disulfide bridges between their free native cysteines in oxidative environment. This is suggested to be essential for aggregation initiation since constructs without cysteines failed to drive the process 27, 28 . Besides, intramolecular disulfide bond formation by cysteine over-oxidation is aggregationinhibitory, presumably because of the lack of free cysteines [29] [30] [31] [32] . Furthermore, 1,2-dihydroxybenzene-containing compounds that bind to and 'cap' cysteine residues also inhibit aggregation 33 . Taken together these data suggest that free/accessible cysteines may be important to drive the first steps of aggregation.
In contrast, others were able to aggregate cysteine-free constructs, although morphology and aggregation propagating capacity of the resulting fibrils were different from wild type fibrils [34] [35] [36] . Furthermore, Tau labelled with fluorescent dyes on artificially introduced cysteines in the Tau-RD aggregated, suggesting that the presence of large modifications on cysteines does not inhibit the process 23 . These data indicate that even though free cysteine side chains may have a role in Tau aggregation, they are not essential.
We set out to understand if labelling the native cysteine residues of Tau has an effect on its aggregation process. Therefore, we labelled aggregation-prone Tau-RD with two dyes forming a FRET-pair and performed aggregation experiments with this sample. We visualised the polymerisation process using blue native-PAGE and in parallel, monitored structural rearrangements by FRET.
We found that the presence of large fluorescent modifications on native cysteines allowed Tau aggregation. The protein formed oligomers and fibrils upon addition of aggregation enhancer. FRET-labels enabled us to follow conformational changes that accompanied the aggregation process. We anticipate that this experimental setup will provide a useful tool to monitor structural changes of aggregating Tau with the 
Results

Labelling of Tau-RD by fluorescent dyes
In our experiments we used a construct that consists of the four pseudo-repeats (R1-R4) of Tau (Tau-RD), Tau(Q244-E372), also referred to as K18 in the literature. This protein is established to aggregate faster than the full length as the termini of Tau have aggregation-inhibitory effect 22, 25, [37] [38] [39] . We modified Tau(Q244-E372) with an N-terminal flag-tag for western blot detection and a K280 deletion that has pro-aggregating effect 40 . We labelled the Tau(Q244-E372) fragment using the FRET-pair Alexa 488 (donor)
and Alexa 594 (acceptor) dyes with maleimide reaction groups to block cysteine residues ( Figure 1B) .
The absorption spectrum of the double-labelled and purified protein showed two maxima at 495 nm and 594 nm, thus, we concluded that simultaneous labelling of Tau(Q244-E372) with Alexa 488 and Alexa 594 was successful and it resulted in double-labelled Tau(Q244-E372) (Tau(Q244-E372) *488D*594A ). This suggests that the cysteines of the Tau(Q244-E372) fragment are accessible. In order to calculate the labelling efficiency we measured the label concentration by absorbance spectroscopy and Tau(Q244-E372) concentration using bicinchoninic colorimetry assay (BCA). Since the Tau(Q244-E372) fragment has two cysteines, at 100% labelling efficiency one mole of Tau(Q244-E372) contains two moles of dye. In our experiments, one mole of Tau(Q244-E372) typically contained between 1.4 and 1.8 moles of dye.
We set out to measure whether we could detect FRET signal in the Tau(Q244-E372) *488D*594A sample. We excited Tau(Q244-E372) *488D*594A at 470 nm since at this wavelength only the donor dye has significant absorbance ( Figure 2A ). We monitored fluorescence emission between 590 and 650 nm as at this wavelength interval the donor dye (Alexa 488) has low, while the acceptor dye (Alexa 594) has high emission ( Figure 2A ). We were able to detect FRET signal in the Tau(Q244-E372) *488D*594A sample ( Figure 2B , black bar).
Since both the donor and the acceptor dyes may have contributed to the measured FRET signal we checked whether we needed to correct for their effect We concluded that the cysteines of Tau(Q244-E372) are accessible and the protein could be labelled simultaneously using multiple different chemicals with maleimide reactive groups. We detected FRET signal in the Tau(Q244-E372)
construct after donor correction, suggesting that the two cysteine residues are within FRET distance from each other.
intramolecular FRET in cysteine-labelled Tau(Q244-E372)
After successful labelling we set out to understand whether the FRET signal we detected in the Tau(Q244-E372) *488D*594A sample resulted from inter-or intramolecular energy transfer. We excited Tau(Q244-E372) *488D*594A and a mix of Tau(Q244-E372) *488D and Tau(Q244-E372) *594A at 470 nm and compared the fluorescence emission spectra of the samples between 590 nm and 650 nm. We expected to detect FRET in both samples if it originates from intermolecular but only in the Tau(Q244-E372) *488D*594A sample if it is the result of intramolecular FRET.
After normalisation and donor correction of the fluorescence emission of Tau(Q244-E372) *488D*594A we observed a peak between 590 and 650 nm indicating that energy transfer occurred ( Figure 3A) . In contrast, we did not observe any peak in the normalised and donor-corrected emission spectrum of the mix of Tau(Q244-E372)
and Tau(Q244-E372) *594A sample between 590 and 650 nm ( Figure 3B ). This suggests that intermolecular interactions did not contribute to the detected FRET signal. We concluded, the FRET signal is a result of intramolecular interactions.
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Tau(Q244-E372) labelled on its native cysteines aggregates
We used the Tau(Q244-E372) *488D*594A construct to test whether the reduction in the number of free cysteines and the presence of large cysteine modifications inhibit the aggregation process as suggested earlier 27, 28 .
We simultaneously aggregated unlabelled Tau(Q244-E372) and Tau(Q244-E372) *488D*594A using heparin, a well-established polyanionic aggregation enhancer of Tau 28, 30, 41 . We took samples at given time points throughout the experiment to be able to visualise the different molecular weight species that have been forming during Tau(Q244-E372) polymerisation and to gain insight into the kinetics of the process. We used blue native-PAGE to separate those species since non-covalent interactions that stabilise oligomers and fibrils remain intact with this method. After running the samples on blue native gels, we transferred them to a membrane and visualised the monomers, oligomers and fibrils/high molecular weight species by blotting for the flag-tag of Tau(Q244-E372).
In the absence of heparin we detected only monomers and oligomers in the Tau(Q244-E372) *488D*594A sample ( Figure 4A ). The amount of these species did not change over time and we did not observe fibril formation. This is consistent with the fact that Tau(Q244-E372) aggregates slowly without heparin. To the contrary, upon addition of heparin the amount of monomers decreased and eventually disappeared over time in the Tau(Q244-E372) *488D*594A sample ( Figure 4A ). We observed first increase and then decline in oligomer amount and gradual fibril formation. We concluded that we were able to initiate the aggregation of Tau(Q244-E372) *488D*594A with the use of heparin.
Consequently, large modifications on the native cysteine residues of Tau(Q244-E372)
did not inhibit the aggregation of the protein.
Next, we set out to test whether the FRET setup allowed us to follow structural rearrangements that accompany aggregation. In the time points of the native gel samples we measured fluorescence emission of Tau(Q244-E372) *488D*594A between 590
and 650 nm at the excitation wavelength of 470 nm. By calculating the percentage change in FRET efficiency we could follow structural rearrangements that accompany aggregation ( Figure 4B ). In the absence of heparin when no aggregation happened 9 ratiometric FRET efficiency did not change over time. In contrast, ratiometric FRET efficiency significantly increased when we aggregated the protein in the presence of heparin, suggesting that compacting accompanied the process.
In summary, we were able to label the repeat domain of Tau using fluorescent dyes that form a FRET-pair. We showed that this construct aggregated in the presence of aggregation enhancer and that FRET was suitable to follow structural rearrangements during the course of aggregation.
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Discussion
We successfully labelled the repeat domain of Tau on its native cysteines using large fluorescent dyes that form a FRET-pair. We detected FRET signal in the double-labelled Tau(Q244-E372) *488D*594A but not in the mix of the single-labelled Tau(Q244-E372) *488D
and Tau(Q244-E372) *594A samples. This suggests that the energy transfer between both dyes of the FRET pair was intramolecular.
According to our results, labelling Tau on its native cysteines enables the aggregation of the protein. This is in contrast with some earlier findings, since the necessity of free cysteines for aggregation was strongly suggested previously [27] [28] [29] [30] [31] [32] . As the labelling efficiencies of our samples were between 70 and 90%, they contained a subpopulation with free cysteines. Therefore, in principle dimer formation via intermolecular disulfide bonds as the primary step of the aggregation could have occurred in our samples. However, we detected oligomerisation and fibrillation in the presence of high concentration of reducing agents, which substantially reduced the chance of covalent dimer formation. Furthermore, we never observed dimers on native gels ( Figure 4A ). Successful aggregation experiments with cysteine-free constructs also argue that covalent dimers are not essential for the process, however, aggregation dynamics and fibril morphology was affected by the absence of cysteines 34, 35 . The differences between these results may originate from variations in the experimental conditions (especially the presence or absence of reducing agents) and the type of modifications.
The presence of large modifications on the native cysteines of Tau did not prevent aggregation in our experiments. This was surprising, because one would expect that bulky dyes inhibited the tight packing of Tau fibrils. Furthermore, it has been shown that shielding natural cysteines by 1,2-dihydroxybenzene-containing compounds has aggregation inhibitory effect 33 . A recent high resolution Cryo-EM structure of full length and truncated Tau aggregates derived from an AD patient, however, significantly improved our understanding of the three dimensional conformation of Tau paired helical filaments 9 . According to this structure Tau adopts a combined cross-β/β-helix
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Aggregation of native cysteine-labelled Tau   11 conformation where C322 is part of the filament core, whereas C291 is in the less ordered β-sheet that folds on the core. Both cysteine residues seem to be accessible, as the authors did not find regular density hinting towards intermolecular disulfide bonds between C322 residues and C291 is located in a relatively disordered region 9 . This suggests that despite the compactness of Tau tangles there is enough room to accommodate modifications covalently attached to Tau's native cysteines. Furthermore, similarly to our experiments labelling of non-natural cysteines by fluorescent dyes enabled aggregation 23 . We concluded that the presence of fluorescent dyes seem to allow the progression of aggregation regardless of their positions.
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Experimental procedures
The ΔK280 (pro-aggregating) His 6 -SUMO-flag- Tau(Q244-E372) 10% acetic acid (Biosolve) and 55% demi water) and destained by destaining solution (30% methanol, 10% acetic acid and 60% demi water).
The density of the flag-ΔK280-Tau(Q244-E372) band was compared to the density of the BSA bands and the concentration of flag-ΔK280-Tau(Q244-E372) was estimated. This was needed because there is a concern that the fluorescent labels interfere with the signal of the BCA Assay.
Aggregation of flag-Tau(Q244-E372)
For flag- Tau(Q244-E372 
Western blot
The aggregation samples were thawed on ice and 1 µl of sample buffer (0.1% Ponceau S (Sigma-Aldrich), 50% glycerol) was added to them. The samples were ran on blue native-PAGE (BN-PAGE) 43 
